Company Overview

Development Stage

About the Company

浙江爱诺生物药业股份有限公司(简称“爱诺药业”)是由原浙江大东吴药业和浙江华圣生物药业组成的一家高新技术生物制药企业。浙江大东吴药业的前身为有近百年历史的湖州制药厂,中间相继被三九制药和浙江大东吴集团收购,2012年7月被我公司整体收购, 2016年7月19日成功登陆北京新三板。公司建有近5万平方米的现代化药品生产基地,拥有片剂、胶囊剂、颗粒剂、口服液、口服溶液剂、外用溶液剂、丸剂、干混悬剂、糖浆剂、煎膏剂以及中药提取等10个剂型4条先进的生产线、61个药品的批件文号、12个产品专利。核心品种有补中益气口服液、炎宁颗粒、痛克搽剂、厄贝沙坦氢氯噻嗪片、恩替卡韦片、姜颗粒、人参珍珠口服液等。其中补中益气口服液是全国独家剂型,*新药品种,国家医保目录产品,浙江等8个省市已进入基药目录;炎宁颗粒是我公司原研药品,具有自主知识产权的中药保护品种,全国仅有2家批准文号,疗效被誉为中成药的“抗生素”;痛克搽剂是*新药,中药保护品种,也是全国*一种从动物多糖生物提取活性成分的骨科外用药;厄贝沙坦氢氯噻嗪片是国家医保目录品种,现在浙江、广东等省市已列入基药目录。同时爱诺药业还拥有自己的研发技术团队,建有独立的研发大楼,拥有实验室、中试车间及配套的检验、试制设备和设施,一直与国内知名科研院所(如浙江大学、浙江工业大学、苏州大学、湖州师范学院等)建立稳定的合作关系,是新产品及人才的孵化基地。目前在研品种有中成药6类新药1个,化学药物(仿制药)3类新药2个。

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

爱诺药业 How Fast Is Hiring Growing? (6 open positions)

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Up 327%
  • 2024: Down 35%
  • 2023: Up 55%
  • 2022: Up 450%
爱诺药业 Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
Note: How fast is hiring at 浙江爱诺生物药业股份有限公司 growing? 爱诺药业2026: 12 openings (down 74%), 2025: 47 openings (up 327%), 2024: 11 openings (down 35%), 2023: 17 openings (up 55%), 2022: 11 openings (up 450%), 2021: 2 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

爱诺药业 — What Are the Salaries Like? (16 records)

Manage
爱诺药业 Salary Overview
salary range: 2K - 50K, 75.1% of roles pay ¥10-50K
Note: salary statistics are based on 16 salary records from the past year and depend on the job sample. For reference only.
How is the salary at 浙江爱诺生物药业股份有限公司?爱诺药业75.1% of positions earn 10-50K, Undergraduate salary: ¥。Huzhou salary ranking top 25,销售类 average salary ¥16.1K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

爱诺药业 honors, qualifications & industry associations

爱诺药业 Related Industry Tags

Tags are auto-annotated by keyword text matching and may be correlated. For reference only.

Job Category

  • 销售类
    56.3% of total 56.3%
  • 工厂生产类
    18.8% of total 18.8%
  • 经营管理类
    18.8% of total 18.8%
  • 医疗卫生/美容保健类
    12.5% of total 12.5%

Education

  • 大专
    68.8% of total 68.8%
  • 本科
    25% of total 25%
  • 不限
    6.3% of total 6.3%

Experience

  • 3-5年
    56.3% of total 56.3%
  • 1-3年
    31.3% of total 31.3%
  • 5-10年
    12.5% of total 12.5%
View Detailed Analysis

What does 浙江爱诺生物药业股份有限公司 require? Who is 爱诺药业 hiring? 爱诺药业 recruitment: 销售类占比最多占56.3%,其次是工厂生产类占18.8%. What education can get in at 爱诺药业? 大专占比最多占68.8%,其次是本科占25%. Work experience required at 爱诺药业? 3-5年占比最多占56.3%,其次是1-3年占31.3%. Where are the job locations at 爱诺药业? 湖州占比最多占50%,其次是嘉兴占12.5%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 6,427.2万(元)
Legal Representative: 陆方明
Date Established:
Credit Code: 9133050075304602XG
Registered Address: 浙江省浙江省湖州市三环东路999号B区7幢

People who follow 爱诺药业 also follow

爱诺药业 Competitors (Similar Companies)

制药/药业 原料药 植物提取 动植物提取物
“To develop high-quality biologics that are accessible and affordable f”
生物制品 生物材料 胶原蛋白 生物发酵
“高端含氟精细化学品研发、生产与销售”
针织 袜子 纱线 家纺
“创新药物研发商”
“Developer and operator of liquid-propellant rockets”
风机 环境科技 实业投资 风机设备
制药/药业 生物制药 凝血因子 生物医药
代餐 生物医药 营养食品 研发
紧固件 汽车零部件/配件 汽车紧固件 阀体
智能机器人 机器人 研发 制造
“愿景:打造国内大型药用真菌制药领域的领头雁”
医药 维生素 维生素生产 维生素E
“Mainly engaged in the production and sales of antibiotics, traditional”

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates